Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C. (Q45126678)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 2008

edit

Language	Label	Description	Also known as
English	Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.	scientific article published in September 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18688878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

title

Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18688878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

main subject

preproinsulin

1 reference

based on heuristic

inferred from title

insulin resistance

1 reference

based on heuristic

inferred from title

steatosis

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author

James G Kench

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18688878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

author name string

Ian Homer Y Cua

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18688878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

Jason M Hui

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18688878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

Jacob George

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18688878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

language of work or name

English

0 references

publication date

1 September 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18688878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

published in

Hepatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18688878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

volume

48

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18688878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18688878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

page(s)

723-731

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18688878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

cites work

Impaired IRS-1/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

21 January 2018

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

21 January 2018

Obesity and non-alcoholic fatty liver disease in chronic hepatitis C.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification of chronic viral hepatitis: a need for reassessment

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonalcoholic fatty liver disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Histopathology of Hepatitis C Virus Infection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Worsening of steatosis and fibrosis progression

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of hepatitis C

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Contribution of obesity to hepatitis C-related fibrosis progression

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of alcohol on the histological and clinical progression of hepatitis C infection

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Steatosis affects chronic hepatitis C progression in a genotype specific way

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Host- and disease-specific factors affecting steatosis in chronic hepatitis C

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Steatosis: co-factor in other liver diseases.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrogenic impact of high serum glucose in chronic hepatitis C.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of connective tissue growth factor in experimental rat and human liver fibrosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FHEP.22392

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/HEP.22392

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18688878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

PubMed publication ID

18688878

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18688878

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688878%20AND%20SRC:MED&resulttype=core&format=json

retrieved

11 January 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45126678&oldid=1590384223"